Demystifying Health Catalyst: Insights From 7 Analyst Reviews

Throughout the last three months, 7 analysts have evaluated Health Catalyst HCAT, offering a diverse set of opinions from bullish to bearish.

The following table summarizes their recent ratings, shedding light on the changing sentiments within the past 30 days and comparing them to the preceding months.

Providing deeper insights, analysts have established 12-month price targets, indicating an average target of $11.29, along with a high estimate of $14.00 and a low estimate of $8.00. Observing a downward trend, the current average is 8.43% lower than the prior average price target of $12.33.

Decoding Analyst Ratings: A Detailed Look

In examining recent analyst actions, we gain insights into how financial experts perceive Health Catalyst. The following summary outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.

Key Insights:

• Action Taken: Responding to changing market dynamics and company performance, analysts update their recommendations. Whether they 'Maintain', 'Raise', or 'Lower' their stance, it signifies their response to recent developments related to Health Catalyst. This offers insight into analysts' perspectives on the current state of the company.
• Rating: Analysts assign qualitative assessments to stocks, ranging from 'Outperform' to 'Underperform'. These ratings convey the analysts' expectations for the relative performance of Health Catalyst compared to the broader market.
• Price Targets: Analysts navigate through adjustments in price targets, providing estimates for Health Catalyst's future value. Comparing current and prior targets offers insights into analysts' evolving expectations.

Capture valuable insights into Health Catalyst's market standing by understanding these analyst evaluations alongside pertinent financial indicators. Stay informed and make strategic decisions with our Ratings Table.

Stay up to date on Health Catalyst analyst ratings.

If you are interested in following small-cap stock news and performance you can start by tracking it here.

Discovering Health Catalyst: A Closer Look

Health Catalyst Inc is engaged in providing data and analytics technology and services to healthcare organizations. It has two operating segments. The Technology segment, which is the key revenue driver, includes data platform, analytics applications and support services. This generates revenues primarily from contracts that are cloud-based subscription arrangements, time-based license arrangements, and maintenance and support fees; and Professional Services segment is generally the combination of analytics, implementation, strategic advisory, outsource, and improvement services to deliver expertise to its customers to more fully configure and utilize the benefits of the technology offerings.

Unraveling the Financial Story of Health Catalyst

Market Capitalization Analysis: The company's market capitalization is below the industry average, suggesting that it is relatively smaller compared to peers. This could be due to various factors, including perceived growth potential or operational scale.

Revenue Growth: Health Catalyst displayed positive results in 3 months. As of 30 September, 2023, the company achieved a solid revenue growth rate of approximately 7.93%. This indicates a notable increase in the company's top-line earnings. In comparison to its industry peers, the company trails behind with a growth rate lower than the average among peers in the Health Care sector.

Net Margin: Health Catalyst's financial strength is reflected in its exceptional net margin, which exceeds industry averages. With a remarkable net margin of -29.86%, the company showcases strong profitability and effective cost management.

Return on Equity (ROE): Health Catalyst's ROE stands out, surpassing industry averages. With an impressive ROE of -5.71%, the company demonstrates effective use of equity capital and strong financial performance.

Return on Assets (ROA): Health Catalyst's ROA surpasses industry standards, highlighting the company's exceptional financial performance. With an impressive -3.07% ROA, the company effectively utilizes its assets for optimal returns.

Debt Management: Health Catalyst's debt-to-equity ratio is below the industry average. With a ratio of 0.65, the company relies less on debt financing, maintaining a healthier balance between debt and equity, which can be viewed positively by investors.

The Basics of Analyst Ratings

Analysts are specialists within banking and financial systems that typically report for specific stocks or within defined sectors. These people research company financial statements, sit in conference calls and meetings, and speak with relevant insiders to determine what are known as analyst ratings for stocks. Typically, analysts will rate each stock once a quarter.

Analysts may enhance their evaluations by incorporating forecasts for metrics like growth estimates, earnings, and revenue, delivering additional guidance to investors. It is vital to acknowledge that, although experts in stocks and sectors, analysts are human and express their opinions when providing insights.

This article was generated by Benzinga's automated content engine and reviewed by an editor.